Opportunity
DIBBS #SPE2DP-26-T-2758
DLA Solicitation for Dicyclomine Hydrochloride Tablets, 20 mg, 100-count Bottles
Posted
April 09, 2026
Respond By
April 14, 2026
Identifier
SPE2DP-26-T-2758
NAICS
424210
This procurement opportunity from the Defense Logistics Agency (DLA) seeks the supply of Dicyclomine Hydrochloride Tablets, USP, 20 mg, for military medical use. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office located at 700 Robbins Avenue, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - Hikma Pharmaceuticals USA Inc. (NDC00143-1227-01) - Upsher-Smith Laboratories, LLC (NDC00832-6052-11) - Chartwell RX LLC (NDC62135-0428-01) - Products Requested: - Dicyclomine Hydrochloride Tablets, USP, 20 mg - NSN: 6505-00-944-4130 / 6505009444130 - Packaged in bottles of 100 tablets - Quantity: 3 bottles - RX only, oral administration - Shelf life: 36 months total, minimum 31 months remaining at receipt - Packaging and marking per Medical Marking Standard No. 1A - Notable Requirements: - Strict compliance with domestic sourcing laws - Must meet technical quality, packaging, and labeling standards - Delivery required within 20 days to Fort Carson, CO - Delivery Location: - Fort Carson, CO (BLDG 7465 BAD TOELZ RD, 80913-4093) - Solicitation is open for offers through the DIBBS portal
Description
DICYCLOMINE HYDROCH (QTY: 3, NSN: 6505-00-944-4130, Purchase Request: 7016240719) Approved Sources: - CAGE: 32655, Part No: NDC00143-1227-01, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 51860, Part No: NDC00832-6052-11, Company: UPSHER-SMITH LABORATORIES, LLC - CAGE: 8APG0, Part No: NDC62135-0428-01, Company: CHARTWELL RX LLC